2002
DOI: 10.1038/sj.cdd.4400931
|View full text |Cite
|
Sign up to set email alerts
|

Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein

Abstract: The Alzheimer amyloid precursor protein (APP) is a transmembrane protein whose abnormal processing is associated with the pathogenesis of Alzheimer's disease. Activated caspases cleave APP and generate its carboxylterminally truncated fragment (APPDC31). We have previously reported that overexpression of wild-type APP induces caspase-3 activation and apoptosis in postmitotic neurons. We now report that APPDC31 potentially plays pathophysiological roles in neuronal death. Adenovirus-mediated overexpression of w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2002
2002
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(12 citation statements)
references
References 44 publications
0
12
0
Order By: Relevance
“…Chromosomal DNA was stained with 5 M Hoechst 33342 (Sigma, St. Louis, MO). For Cdc2 immunohistochemistry, paraffin-embedded 8-m-thick sections were incubated with antibodies against Cdc2 [p34 (17), 1:200; Santa Cruz Biotechnology, Santa Cruz, CA] and activated caspase-3 (ACP3, 1:1000) Nishimura et al, 2002) in PBS containing 0.05% Triton X-100 and 2% normal goat serum at room temperature for 12 h, and with secondary antibodies as above. The Cdc2-immunoreactive cells in folium III, which was readily distinguishable from other cerebellar folia, were counted.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Chromosomal DNA was stained with 5 M Hoechst 33342 (Sigma, St. Louis, MO). For Cdc2 immunohistochemistry, paraffin-embedded 8-m-thick sections were incubated with antibodies against Cdc2 [p34 (17), 1:200; Santa Cruz Biotechnology, Santa Cruz, CA] and activated caspase-3 (ACP3, 1:1000) Nishimura et al, 2002) in PBS containing 0.05% Triton X-100 and 2% normal goat serum at room temperature for 12 h, and with secondary antibodies as above. The Cdc2-immunoreactive cells in folium III, which was readily distinguishable from other cerebellar folia, were counted.…”
Section: Methodsmentioning
confidence: 99%
“…Frozen sections of the cerebellum of ICR mice (SLC, Shizuoka, Japan) at postnatal day 6 (P6) and cultured CGNs were prepared for staining as described previously (Nishimura et al, 1998;Nishimura et al, 2002). Fixed tissues and cells were incubated with primary antibodies against necdin (NC243, 1:500) , Ki67…”
Section: Methodsmentioning
confidence: 99%
“…APP is a transmembrane protein and its proteolytic processing generates a 39 -42 residue peptides referred to as ␤-amyloid (A␤). A␤ peptides are the primary constituents of amyloid deposits found in the aging brain and have been implicated in the pathogenesis of Alzheimer's disease (AD) and Down syndrome by genetic, pathologic, and biochemical evidence (Selkoe, 2001;Nishimura et al, 2002;Lahiri et al, 2003). Therefore, we also examined APP and A␤ levels in old rat brains developmentally exposed to Pb.…”
Section: Introductionmentioning
confidence: 99%
“…Production of C31 is a result of APP cleavage at the caspase site D720 of the C-terminus. Following caspase 3 activation, caspase 3 generates the carboxyl-terminally truncated fragment C31 from APP, which has been shown to be capable of apoptotic injury independent of caspase 3 [165]. Furthermore, caspase-dependent APP cleavage at D720 has also been observed in brains of Alzheimer's disease patients through demonstration of C31 expression [132].…”
Section: Processing Of App By Secretases and Caspasesmentioning
confidence: 98%
“…5). The generation of the C-terminal fragment C31 results from the cleavage of APP at the caspase site D720 of the C-terminus by caspase 3 [165]. Once generated, C31 enhances glycogen synthase kinase-3β expression and tau protein phosphorylation [107].…”
Section: The Forkhead Transcription Factor Glycogen Synthase Kinase-mentioning
confidence: 99%